{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:13:39Z","timestamp":1788952419615,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018573","name":"Sun Yat-sen University Cancer Center","doi-asserted-by":"publisher","award":["CIRP-SYSUCC-0019"],"award-info":[{"award-number":["CIRP-SYSUCC-0019"]}],"id":[{"id":"10.13039\/501100018573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403653"],"award-info":[{"award-number":["82403653"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1104002"],"award-info":[{"award-number":["2022YFA1104002"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154458","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:21:50Z","timestamp":1787034110000},"page":"154458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A nuclear-targeted PROTAC enables subcellular-selective degradation of AURKA"],"prefix":"10.1016","volume":"834","author":[{"given":"Bowen","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-2805","authenticated-orcid":false,"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0999-9805","authenticated-orcid":false,"given":"Zifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-2769","authenticated-orcid":false,"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-5715","authenticated-orcid":false,"given":"Daqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-616X","authenticated-orcid":false,"given":"Xinxing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9347-8243","authenticated-orcid":false,"given":"Shijun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-370X","authenticated-orcid":false,"given":"Zhijie","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154458_bib1","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1038\/s41388-021-01766-w","article-title":"Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer","volume":"40","author":"Naso","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154458_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biom9010028","article-title":"Aurora A protein kinase: to the centrosome and beyond","volume":"9","author":"Magnaghi-Jaulin","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.154458_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/med.21399","article-title":"Aurora-A kinase: A potent oncogene and target for cancer therapy","volume":"36","author":"Yan","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2026.154458_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1369\/jhc.6A7077.2007","article-title":"Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry","volume":"55","author":"Burum-Auensen","year":"2007","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbrc.2026.154458_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12885-015-1329-3","article-title":"Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma","volume":"15","author":"Tamotsu","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154458_bib6","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/modpathol.2008.173","article-title":"Aurora-A kinase nuclear expression in chronic lymphocytic leukemia","volume":"21","author":"Inamdar","year":"2008","journal-title":"Modern. Pathol."},{"key":"10.1016\/j.bbrc.2026.154458_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/mc.20525","article-title":"Oncogenic role of nuclear accumulated Aurora-A","volume":"48","author":"Tatsuka","year":"2009","journal-title":"Mol Carcinogen."},{"key":"10.1016\/j.bbrc.2026.154458_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2282184","article-title":"Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA","volume":"56","author":"Chen","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbrc.2026.154458_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10180","article-title":"Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype","volume":"7","author":"Zheng","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154458_bib10","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1038\/onc.2016.490","article-title":"FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells","volume":"36","author":"Yang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154458_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41422-020-00397-2","article-title":"Oncogenic AURKA-enhanced N(6)-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells","volume":"31","author":"Peng","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrc.2026.154458_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in Cancer: molecular mechanisms and opportunities for cancer therapy","volume":"20","author":"Du","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154458_bib13","doi-asserted-by":"crossref","first-page":"22095","DOI":"10.1021\/acs.jmedchem.5c02127","article-title":"Beyond inhibition: recent advances of heterobifunctional molecules targeting CDK9","volume":"68","author":"Yin","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020690","article-title":"Emerging TACnology: heterobifunctional small molecule inducers of targeted posttranslational protein modifications","volume":"28","author":"Heitel","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.154458_bib15","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1021\/acs.jmedchem.2c00316","article-title":"Beyond proteolysis-targeting chimeric molecules: designing heterobifunctional molecules based on functional effectors","volume":"65","author":"Hua","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein degraders enter the clinic - a new approach to cancer therapy","volume":"20","author":"Chirnomas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154458_bib17","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1080\/14796694.2024.2377530","article-title":"VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+\/HER2- advanced breast cancer","volume":"20","author":"Hamilton","year":"2024","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbrc.2026.154458_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41589-020-00652-y","article-title":"PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase","volume":"16","author":"Adhikari","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154458_bib19","article-title":"A temporal PROTAC cocktail-mediated sequential degradation of AURKA abrogates Acute Myeloid Leukemia stem cells","volume":"9","author":"Liu","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbrc.2026.154458_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27959","article-title":"AURKA promotes renal cell carcinoma progression via regulation of CCNB1 transcription","volume":"10","author":"Wen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.154458_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216939","article-title":"SOX9 is regulated by AURKA in response to Helicobacter pylori infection via EIF4E-mediated cap-dependent translation","volume":"593","author":"Gomaa","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154458_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202415458","article-title":"FBXO44 regulates FOXP1 degradation through AURKA-dependent phosphorylation to promote colorectal cancer progression","volume":"12","author":"Nie","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbrc.2026.154458_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-022-00905-3","article-title":"Nuclear Aurora kinase A switches m(6)A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4","volume":"7","author":"Li","year":"2022","journal-title":"Signal. Transduct. Tar."},{"key":"10.1016\/j.bbrc.2026.154458_bib24","article-title":"Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer","volume":"9","author":"Li","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.154458_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108000","article-title":"Proteomic study identifies Aurora-A-mediated regulation of alternative splicing through multiple splicing factors","volume":"301","author":"Damodaran","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib26","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1093\/nar\/gkaa570","article-title":"A kinase-independent function for AURORA-A in replisome assembly during DNA replication initiation","volume":"48","author":"Guarino","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154458_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8916729","article-title":"AURKA increase the chemosensitivity of Colon cancer cells to oxaliplatin by inhibiting the TP53-Mediated DNA damage response genes","volume":"2020","author":"Shan","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2026.154458_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1083\/jcb.201803003","article-title":"Mitotic regulators TPX2 and Aurora A protect DNA forks during replication stress by counteracting 53BP1 function","volume":"218","author":"Byrum","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154458_bib29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s42003-021-02158-2","article-title":"Selective targeting of non-centrosomal AURKA functions through use of a targeted protein degradation tool","volume":"4","author":"Wang","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2026.154458_bib30","unstructured":"A. Cardno, K. Roberts, C. Lindon, Efficiency and localisation of AURKA degradation by PROTACs is modulated by deubiquitinases UCHL5 and target-selective OTUD6A, eLife."},{"key":"10.1016\/j.bbrc.2026.154458_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108633","article-title":"Aurora kinases, emerging critical targets for cancer treatment and related new therapeutic strategies","volume":"163","author":"Chung","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41589-019-0279-5","article-title":"Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16","volume":"15","author":"Zhang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154458_bib33","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1021\/jacs.2c00874","article-title":"Hijacking methyl reader proteins for nuclear-specific protein degradation","volume":"144","author":"Nalawansha","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbrc.2026.154458_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nchembio.1157","article-title":"Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain","volume":"9","author":"James","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154458_bib35","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s41467-018-04019-9","article-title":"Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4(DCAF5) ubiquitin ligase","volume":"9","author":"Leng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154458_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1074\/jbc.RA118.005336","article-title":"Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4(DCAF5) ubiquitin ligase","volume":"294","author":"Zhang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib37","article-title":"L3MBTL3 is induced by HIF-1alpha and fine tunes the HIF-1alpha degradation under hypoxia in vitro","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.154458_bib38","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1093\/nar\/gkv226","article-title":"Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference","volume":"43","author":"Barrangou","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154458_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34595","article-title":"Estimating the protein burden limit of yeast cells by measuring the expression limits of glycolytic proteins","volume":"7","author":"Eguchi","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.bbrc.2026.154458_bib40","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201726","article-title":"AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation","volume":"6","author":"Asteriti","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bbrc.2026.154458_bib41","first-page":"209","article-title":"Myeloid toxicity of cancer treatment","volume":"3","author":"Kurtin","year":"2012","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.bbrc.2026.154458_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40265-020-01461-2","article-title":"Inhibiting CDK4\/6 in breast cancer with palbociclib, ribociclib, and abemaciclib: similarities and differences","volume":"81","author":"Braal","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2026.154458_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1495","article-title":"CDK4 and CDK6 kinases: from basic science to cancer therapy","volume":"375","author":"Fassl","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154458_bib44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.18.00899","article-title":"Randomized phase III Study of Alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma","volume":"37","author":"O'Connor","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154458_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-18-0469","article-title":"Aurora A kinase inhibition is synthetic lethal with loss of the RB1 tumor suppressor gene","volume":"9","author":"Gong","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2026.154458_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161929","article-title":"Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression","volume":"133","author":"Wang","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154458_bib47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/cac2.12190","article-title":"Nuclear Aurora kinase A triggers programmed death-ligand 1-mediated immune suppression by activating MYC transcription in triple-negative breast cancer","volume":"41","author":"Sun","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bbrc.2026.154458_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40364-024-00651-4","article-title":"The significant others of aurora kinase a in cancer: combination is the key","volume":"12","author":"Nikhil","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbrc.2026.154458_bib49","article-title":"Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells","volume":"9","author":"Yang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.154458_bib50","article-title":"The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma","volume":"5","author":"Liu","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2026.154458_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.37349\/etat.2020.00018","article-title":"Current strategies for the design of PROTAC linkers: a critical review","volume":"1","author":"Troup","year":"2020","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.bbrc.2026.154458_bib52","doi-asserted-by":"crossref","first-page":"23962","DOI":"10.1021\/acs.jmedchem.5c01271","article-title":"Second-generation AURKA-targeting PROTACs: structural optimization toward in vivo degradation in Neuroblastoma","volume":"68","author":"Simon Krols","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acschembio.7b00549","article-title":"CRISPR-Mediated tagging of endogenous proteins with a luminescent peptide","volume":"2","author":"Schwinn","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154458_bib54","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1002\/cbic.202100164","article-title":"Recent developments and strategies for mutually orthogonal bioorthogonal reactions","volume":"2","author":"Hu","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbrc.2026.154458_bib55","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-021-00245-x","article-title":"The PROTACtable genome","volume":"20","author":"Schneider","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.154458_bib56","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1038\/s41467-023-42233-2","article-title":"Expanding PROTACtable genome universe of E3 ligases","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154458_bib57","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41591-019-0668-z","article-title":"A selective BCL-X(L) PROTAC degrader achieves safe and potent antitumor activity","volume":"25","author":"Khan","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.154458_bib58","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.chembiol.2022.08.004","article-title":"Target protein localization and its impact on PROTAC-mediated degradation","volume":"29","author":"Simpson","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154458_bib59","doi-asserted-by":"crossref","first-page":"8634","DOI":"10.1021\/acs.jmedchem.5c00295","article-title":"Harnessing the SPOP E3 ubiquitin ligase via a bridged proteolysis targeting chimera (PROTAC) strategy for targeted protein degradation","volume":"68","author":"Deng","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib60","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1042\/BCJ20243018","article-title":"Methods to accelerate PROTAC drug discovery","volume":"482","author":"Osman","year":"2025","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2026.154458_bib61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.154458_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103395","article-title":"PROTAC technology: a new drug design for chemical biology with many challenges in drug discovery","volume":"28","author":"Guedeney","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2026.154458_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112981","article-title":"Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: recent progress and future challenges","volume":"210","author":"Zeng","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib64","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1021\/acs.jmedchem.3c01007","article-title":"Discovery and preclinical pharmacology of NX-2127, an orally bioavailable degrader of Bruton's tyrosine kinase with immunomodulatory activity for the treatment of patients with B cell malignancies","volume":"67","author":"Robbins","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib65","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.jmedchem.6b01912","article-title":"Impact of target warhead and linkage vector on inducing protein degradation: comparison of bromodomain and extra-terminal (BET) degraders derived from triazolodiazepine (JQ1) and tetrahydroquinoline (I-BET726) BET inhibitor scaffolds","volume":"61","author":"Chan","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154458_bib66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.chembiol.2024.12.006","article-title":"Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders","volume":"32","author":"Tang","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154458_bib67","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26012222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26012222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:32:01Z","timestamp":1788949921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26012222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"alternative-id":["S0006291X26012222"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154458","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nuclear-targeted PROTAC enables subcellular-selective degradation of AURKA","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154458"}}